Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
9
×
life sciences
national blog main
san francisco blog main
9
×
biotech
boston blog main
boston top stories
clinical trials
national top stories
san francisco top stories
new york blog main
new york top stories
raleigh-durham blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
investing
ipo
medical devices
national
startups
biofourmis
black diamond therapeutics
boston
chronic kidney disease
crispr
What
therapeutics
9
×
drug
ipo
companies
medicines
million
momentum
new
treat
approved
bio
black
cancer
diamond
digital
fda
immunotherapy
latest
leading
life
raised
roundup
science
therapy
week
affects
agency
aimmune
allergy
allogene
americans
analytics
announced
approval
awarded
backs
bets
biofourmis
biotech
biotechs
Language
unset
Current search:
fda
×
therapeutics
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed